Tod Woolf - Net Worth and Insider Trading

Tod Woolf Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tod Woolf owns 1 companies in total, including SELLAS Life Sciences Group Inc (SLS) .

Click here to see the complete history of Tod Woolf’s form 4 insider trades.

Insider Ownership Summary of Tod Woolf

Ticker Comapny Transaction Date Type of Owner
SLS SELLAS Life Sciences Group Inc 2008-02-14 director & President and CEO

Tod Woolf Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Tod Woolf Ownership Network

Ownership Network List of Tod Woolf

No Data

Ownership Network Relation of Tod Woolf

Insider Network Chart

Tod Woolf Owned Company Details

What does SELLAS Life Sciences Group Inc do?

Who are the key executives at SELLAS Life Sciences Group Inc?

Tod Woolf is the director & President and CEO of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .

SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

SELLAS Life Sciences Group Inc Insider Transactions

No Available Data

Tod Woolf Mailing Address

Above is the net worth, insider trading, and ownership report for Tod Woolf. You might contact Tod Woolf via mailing address: C/o Rxi Pharmaceuticals Corporation, 60 Prescott Street, Worcester Ma 01605.

Discussions on Tod Woolf

No discussions yet.